Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

FDA Commissioner Scott Gottlieb to resign

Kyle Brasseur | March 5, 2019

Scott Gottlieb, commissioner of the Food and Drug Administration, announced Tuesday that he will leave his post within the next month.

“There’s perhaps nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years and missing my wife and three young children,” Gottlieb said in a statement.

“This is a very special institution, and the work that binds us in a shared mission is inspiring. I know that the opportunity to serve in this role was a privilege, and an endeavor that I’ll never be able to replicate in my professional life.”

Gottlieb was appointed commissioner by President Donald Trump and confirmed by the Senate on May 9, 2017. He had previously served the FDA as its deputy commissioner for medical and scientific affairs.

“Scott has helped us to lower drug prices, get a record number of generic drugs approved and onto...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.